T1	Participants 55 96	chemotherapy for advanced gastric cancer.
T2	Participants 213 282	the proliferative ability of cancer cells in gastric cancer patients.
T3	Participants 291 376	Chemotherapy was performed for 72 h before gastrectomy in 63 gastric cancer patients.
T4	Participants 386 714	were classed into four groups: Group F, 16 cases who received a single administration of 5-fluorouracil (5-FU); Group C, 15 cases who received a single administration of cis-diamminedichloroplatinum (CDDP; cisplatin); Group FC, 16 cases who received both 5-FU+CDDP; and a Control group, 16 cases who did not receive chemotherapy
